Contraceptives: Technologies and Global Markets

Published - May 2010| Analyst - Shalini Shahani Dewan| Code - HLC085A
Market Research Report Single User License: $2,750 Member Price: FREE

Report Highlights

  • Global sales of contraceptives in 2008 were $9.9 billion and, with 2% growth, sales reached $10.1 billion in 2009.  This market is expected to rise at a CAGR of 4.8% and reach $13.5 billion by 2015.
  • The contraceptive market is led by hormonal contraceptives with more than a 78% share. This segment was worth $7.9 billion in 2009 and is expected to increase to $8.2 billion in 2010 and $9.4 billion by 2015, a compound annual growth rate of (CAGR) of 2.8%. 
  • Barrier contraceptives have a smaller market share than hormonal contraceptives but are expected to grow at a higher rate. This segment was worth $2 billion in 2009 and is expected to be valued at $2.3 billion in 2010 and $3.5 billion in 2015, an 8.5% compound annual growth rate (CAGR).

INTRODUCTION 

STUDY OBJECTIVES
 
BCC’s goal in conducting this study is to provide an overview of the current and future characteristics of the global market for contraceptive products and technologies in today’s world. The key objective is to present a comprehensive analysis of the current contraceptive market and its future direction as an important method for control over child birth—and hence the population—and also as a method of protection from sexually transmitted diseases.
 
This report explores present and future strategies within the contraceptive industry, including the prevalence and market trends of the products used. The improvisation of the market, the setbacks, and the needs of the market are discussed, as well as various types of contraceptive methods, their usage and efficacy, and the technologies used in the past and present.
 
A detailed analysis of the contraceptive industry structure has been conducted, which includes the manufacturing of various types of contraceptives. Revenues are broken down by region. Sales figures are estimated for the 5–year period from 2010 through 2015. 
 
Prevalence of contraceptive methods are also discussed separately in the report, with an explanation of the decreased use in some countries. The report also covers significant patents and their allotments in each category.
 
REASONS FOR DOING THIS STUDY
 
This study was conducted to provide an update of new developments in the market of contraception technology and to provide detailed market analysis of contraceptive products along with the factors affecting this market. This industry was influenced by the economic downturn, but unlike other industries it was affected in a positive way. The advancements and the need for better and safer contraception methods have always influenced market growth. This study analyzes almost all the systems affected by these factors. 
 
Acquisition strategies and collaborations by companies are covered in this report, as well as the strength and weaknesses of each type of contraception method in light of new technologies, growing competition, and changing customer needs.
 
INTENDED AUDIENCE
 
This study contributes to the areas of market growth in contraception through contraceptive products and technologies from the point of view of manufacturers and users. Analytical companies, physicians, the pharmaceutical and biopharmaceutical industries, hospitals and research institutes will find this study to be of interest. 
 
SCOPE OF REPORT
 
The scope of this study encompasses the contraception markets. BCC analyzes each market by its prevalence, method of usage, regulatory environment, technology, market projections, and market share. Technological issues include the latest trends and developments. The study also includes women at risk and other factors influencing the market.
 
METHODOLOGY
 
Both primary and secondary research methodologies were used in this study. BCC conducted a comprehensive literature search, which included technical newsletters and journals, and many other sources. Data was collected through online research and correspondence with various analytical/chemical/pharmaceutical/biotechnical experts. 
 
INFORMATION SOURCES
 
Many companies within the industry were surveyed to obtain data for this study. Included were manufacturers and suppliers of contraceptives. Data was gathered from various industry sources. BCC consulted and surveyed all the possible resources within the industry, consulted newsletters, company literature, product literature, and a host of technical articles, journals, indexes, and abstracts. Exhaustive investigations of databases by key terminology were completed. In addition, data was compiled from current financial, trade, and government sources.
 
ABOUT THE AUTHOR
 
Shalini S. Dewan holds a master’s degree in pharmaceutical chemistry. Among the research topics she has covered are studies on compounds of potential pharmaceutical interest from ibuprofen and 2–naphthylacetic acid. Shalini was awarded a Gold Medal by the Prime Minister of India for her work and has worked with top companies in India and in the U.S. Some of her other reports with BCC are Reagents for Chromatography; Spectroscopy, an Enduring Market; Advanced Drug Delivery Systems; Orthopedic Drugs, Implants and Devices; Imaging Reagents; Regulatory Industry; and Dynamic Sera, Media and Reagents Used in Biotechnology.
  
BCC ONLINE SERVICES
 
BCC offers an online information retrieval service. BCC’s home page, located at www.bccresearch.com, enables readers to:
  • Examine BCC’s complete catalog of Market Research Reports and place direct orders
  • Subscribe to any of BCC’s many industry newsletters
  • Read announcements of recently published reports and newly launched newsletters
  • Register for BCC’s well-known conferences
  • Request additional information on any BCC product
  • Take advantage of special offers
DISCLAIMER
 
The information developed in this report is intended to be as reliable as possible at the time of publication and of a professional nature. This information does not constitute managerial, legal, or accounting advice; nor should it serve as a corporate policy guide, laboratory manual, or an endorsement of any product, as much of the information is speculative in nature. The author assumes no responsibility for any loss or damage that might result from reliance on the reported information or its use.

Table of Contents & Pricing

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Note: Reports are discounted or included with certain Memberships. See Membership Options.
 
Need Specific Data Sets?

We can tailor to your project.

Contact Us
RELATED REPORTS
Share This Report